168 related articles for article (PubMed ID: 11380394)
21. Ikaros and leukaemia.
Olsson L; Johansson B
Br J Haematol; 2015 May; 169(4):479-91. PubMed ID: 25753742
[TBL] [Abstract][Full Text] [Related]
22. Re-induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.
Raetz EA; Cairo MS; Borowitz MJ; Lu X; Devidas M; Reid JM; Goldenberg DM; Wegener WA; Zeng H; Whitlock JA; Adamson PC; Hunger SP; Carroll WL
Pediatr Blood Cancer; 2015 Jul; 62(7):1171-5. PubMed ID: 25732247
[TBL] [Abstract][Full Text] [Related]
23. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.
Dhédin N; Huynh A; Maury S; Tabrizi R; Beldjord K; Asnafi V; Thomas X; Chevallier P; Nguyen S; Coiteux V; Bourhis JH; Hichri Y; Escoffre-Barbe M; Reman O; Graux C; Chalandon Y; Blaise D; Schanz U; Lhéritier V; Cahn JY; Dombret H; Ifrah N;
Blood; 2015 Apr; 125(16):2486-96; quiz 2586. PubMed ID: 25587040
[TBL] [Abstract][Full Text] [Related]
24. The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia.
Cheng Y; Luo Z; Yang S; Jia M; Zhao H; Xu W; Tang Y
Leuk Res; 2015 Feb; 39(2):144-50. PubMed ID: 25542697
[TBL] [Abstract][Full Text] [Related]
25. Update on biology and treatment of T-cell acute lymphoblastic leukaemia.
Patrick K; Vora A
Curr Opin Pediatr; 2015 Feb; 27(1):44-9. PubMed ID: 25502893
[TBL] [Abstract][Full Text] [Related]
26. Detection of dicentric chromosome (9;20) in paediatric B-cell acute lymphoblastic leukaemia: prognostic significance.
Letouzey M; Penther D; Roche-Lestienne C; Nelken B; Devoldère C; Vannier JP; Schneider P
Ann Hematol; 2015 Feb; 94(2):187-93. PubMed ID: 25193356
[TBL] [Abstract][Full Text] [Related]
27. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
28. Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.
Beldjord K; Chevret S; Asnafi V; Huguet F; Boulland ML; Leguay T; Thomas X; Cayuela JM; Grardel N; Chalandon Y; Boissel N; Schaefer B; Delabesse E; Cavé H; Chevallier P; Buzyn A; Fest T; Reman O; Vernant JP; Lhéritier V; Béné MC; Lafage M; Macintyre E; Ifrah N; Dombret H;
Blood; 2014 Jun; 123(24):3739-49. PubMed ID: 24740809
[TBL] [Abstract][Full Text] [Related]
29. IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome.
Russell LJ; Enshaei A; Jones L; Erhorn A; Masic D; Bentley H; Laczko KS; Fielding AK; Goldstone AH; Goulden N; Mitchell CD; Wade R; Vora A; Moorman AV; Harrison CJ
J Clin Oncol; 2014 May; 32(14):1453-62. PubMed ID: 24711557
[TBL] [Abstract][Full Text] [Related]
30. Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia.
Poopak B; Saki N; Purfatholah AA; Najmabadi H; Mortazavi Y; Arzanian MT; Khosravipour G; Haghnejad F; Salari F; Shahjahani M
Hematology; 2014 Jul; 19(5):259-66. PubMed ID: 24620952
[TBL] [Abstract][Full Text] [Related]
31. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
[TBL] [Abstract][Full Text] [Related]
32. Outcome of TCF3-PBX1 positive pediatric acute lymphoblastic leukemia patients in Japan: a collaborative study of Japan Association of Childhood Leukemia Study (JACLS) and Children's Cancer and Leukemia Study Group (CCLSG).
Asai D; Imamura T; Yamashita Y; Suenobu S; Moriya-Saito A; Hasegawa D; Deguchi T; Hashii Y; Endo M; Hatakeyama N; Kawasaki H; Hori H; Horibe K; Yumura-Yagi K; Hara J; Watanabe A; Kikuta A; Oda M; Sato A;
Cancer Med; 2014 Jun; 3(3):623-31. PubMed ID: 24578304
[TBL] [Abstract][Full Text] [Related]
33. Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.
Karsa M; Dalla Pozza L; Venn NC; Law T; Shi R; Giles JE; Bahar AY; Cross S; Catchpoole D; Haber M; Marshall GM; Norris MD; Sutton R
PLoS One; 2013; 8(10):e76455. PubMed ID: 24146872
[TBL] [Abstract][Full Text] [Related]
34. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
Hoelzer D
Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
[TBL] [Abstract][Full Text] [Related]
35. Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.
van der Veer A; Waanders E; Pieters R; Willemse ME; Van Reijmersdal SV; Russell LJ; Harrison CJ; Evans WE; van der Velden VH; Hoogerbrugge PM; Van Leeuwen F; Escherich G; Horstmann MA; Mohammadi Khankahdani L; Rizopoulos D; De Groot-Kruseman HA; Sonneveld E; Kuiper RP; Den Boer ML
Blood; 2013 Oct; 122(15):2622-9. PubMed ID: 23974192
[TBL] [Abstract][Full Text] [Related]
36. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
37. Use of allogeneic hematopoietic stem-cell transplantation based on minimal residual disease response improves outcomes for children with relapsed acute lymphoblastic leukemia in the intermediate-risk group.
Eckert C; Henze G; Seeger K; Hagedorn N; Mann G; Panzer-Grümayer R; Peters C; Klingebiel T; Borkhardt A; Schrappe M; Schrauder A; Escherich G; Sramkova L; Niggli F; Hitzler J; von Stackelberg A
J Clin Oncol; 2013 Jul; 31(21):2736-42. PubMed ID: 23775972
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody-based therapies in the treatment of acute lymphoblastic leukemia.
Litzow MR
Am Soc Clin Oncol Educ Book; 2013; ():294-9. PubMed ID: 23714527
[TBL] [Abstract][Full Text] [Related]
39. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
40. Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia.
Ardjmand A; de Bock CE; Shahrokhi S; Lincz LF; Boyd AW; Burns GF; Thorne RF
Hematology; 2013 Nov; 18(6):315-22. PubMed ID: 23433465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
